Literature DB >> 17559203

Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Christophe Hardouin1, Michael J Kelso, F Anthony Romero, Thomas J Rayl, Donmienne Leung, Inkyu Hwang, Benjamin F Cravatt, Dale L Boger.   

Abstract

A systematic study of the structure-activity relationships of 2b (OL-135), a potent inhibitor of fatty acid amide hydrolase (FAAH), is detailed targeting the C2 acyl side chain. A series of aryl replacements or substituents for the terminal phenyl group provided effective inhibitors (e.g., 5c, aryl = 1-napthyl, Ki = 2.6 nM), with 5hh (aryl = 3-ClPh, Ki = 900 pM) being 5-fold more potent than 2b. Conformationally restricted C2 side chains were examined, and many provided exceptionally potent inhibitors, of which 11j (ethylbiphenyl side chain) was established to be a 750 pM inhibitor. A systematic series of heteroatoms (O, NMe, S), electron-withdrawing groups (SO, SO2), and amides positioned within and hydroxyl substitutions on the linking side chain were investigated, which typically led to a loss in potency. The most tolerant positions provided effective inhibitors (12p, 6-position S, Ki = 3 nM, or 13d, 2-position OH, Ki = 8 nM) comparable in potency to 2b. Proteome-wide screening of selected inhibitors from the systematic series of >100 candidates prepared revealed that they are selective for FAAH over all other mammalian serine proteases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559203      PMCID: PMC2531194          DOI: 10.1021/jm061414r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  70 in total

1.  Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist.

Authors:  S R Fernando; R G Pertwee
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

2.  Anandamide may mediate sleep induction.

Authors:  R Mechoulam; E Fride; L Hanus; T Sheskin; T Bisogno; V Di Marzo; M Bayewitch; Z Vogel
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

3.  A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Authors:  Raquel Gómez; Miguel Navarro; Belén Ferrer; José M Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

4.  Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide.

Authors:  D L Boger; J E Patterson; X Guan; B F Cravatt; R A Lerner; N B Gilula
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 5.  Cannabinoid receptors and their endogenous agonist, anandamide.

Authors:  J Axelrod; C C Felder
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

6.  Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats.

Authors:  S Huitrón-Reséndiz; L Gombart; B F Cravatt; S J Henriksen
Journal:  Exp Neurol       Date:  2001-11       Impact factor: 5.330

7.  Observational analysis of feeding induced by Delta9-THC and anandamide.

Authors:  Claire M Williams; Tim C Kirkham
Journal:  Physiol Behav       Date:  2002-06-01

8.  Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.

Authors:  D L Boger; J E Patterson; Q Jin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

9.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

10.  The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells.

Authors:  X Guan; B F Cravatt; G R Ehring; J E Hall; D L Boger; R A Lerner; N B Gilula
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  26 in total

1.  Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Authors:  Jessica K DeMartino; Joie Garfunkle; Dustin G Hochstatter; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

Review 2.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 3.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

4.  Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders.

Authors:  Kay Ahn; Douglas S Johnson; Benjamin F Cravatt
Journal:  Expert Opin Drug Discov       Date:  2009-07       Impact factor: 6.098

5.  Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

6.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

7.  A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

Authors:  Victoria Magrioti; George Naxakis; Dimitra Hadjipavlou-Litina; Alexandros Makriyannis; George Kokotos
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

8.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

9.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  Discovery libraries targeting the major enzyme classes: the serine hydrolases.

Authors:  Katerina Otrubova; Venkat Srinivasan; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.